Skip to content
Home/Companies/Biotech/Integragen
IN

Integragen

Biotech·France·Exited 2020·Held 10yr

Integragen is a biotech company, headquartered in France.

Entry
2010
Hold
10yr
Exit
2020
Est. EV
–

Who owns Integragen?

Integragen was owned by Generis Capital Partners through FPCI Entreprise & Croissance I (2018 vintage) from 2010 to 2020, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-10

Generis Capital Partners
Investor
Generis Capital Partners
FPCI Entreprise & Croissance I · 2018 · Growth

Key facts

HQFrance
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2020

More from FPCI Entreprise & Croissance I

Other portfolio companies in the same fund.

Antoli
Active
Business ServicesFrance· 2025
APEX Digital
Active
MedTechFrance· 2025
Luquet & Duranton
Active
Business ServicesFrance· 2025
Semco
Active
IndustrialsFrance· 2025
Transfert
Active
Business ServicesFrance· 2025
Act for Sport
Active
Business ServicesFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings